Skip to content

OPKO HEALTH, INC.

OPK

CIK 0000944809 · Pharmaceutical Preparations · Nasdaq

  • EXEGENICS INC (until 2007-06-13)
  • eXegenics Inc (until 2007-06-13)
  • CYTOCLONAL PHARMACEUTICS INC /DE (until 2001-06-04)
← back to feed
Revenue (TTM)
$582.62M
−2.1% YoY Q1 Apr 2026
Net Income (TTM)
−$249.27M
−244.5% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.33
−233.3% YoY Q1 Apr 2026
Gross Margin
32.2%
Q1 Apr 2026
Operating Margin
-22.3%
Q1 Apr 2026
Net Margin
-42.8%
Q1 Apr 2026
Free Cash Flow (TTM)
−$124.58M
Q1 Apr 2026
Cash
$331.86M
Q1 Apr 2026
Total Debt
$3.54M
Q1 Apr 2026
Shares Outstanding
755.09M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings